Omnicare, a CVS Health subsidiary, has entered an asset purchase agreement with GenieRx, which will act as the stalking horse bidder in Omnicare's court-supervised sale process. This agreement sets a minimum price for Omnicare's assets, with other bidders able to submit competing offers by April 30, 2026. An auction is expected on May 5, 2026, followed by a court hearing to approve the sale. Omnicare continues to support its long-term care pharmacy services during the sale process, emphasizing quality care for senior living and skilled nursing communities.
Aetna's latest survey shows U.S. healthcare providers' trust in payers increased to a score of 6.1 from 5.4, reflecting improved perceptions of payer reliability and communication. Providers highlight technology's role in reducing administrative task...
CVS Caremark announced a global settlement with the Federal Trade Commission (FTC) resolving all litigation related to rebate practices, pharmacy network contracting, and vertical integration. The agreement ends ongoing investigations and allows CVS ...
